Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century

F. Zitricky, AI. Koskinen, O. Hemminki, A. Försti, A. Hemminki, K. Hemminki

. 2024 ; 13 (1) : e6867. [pub] 20240102

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24020054

Grantová podpora
European Union's Horizon 2020, grant no. 856620 (Chaperon)

BACKGROUND: Cancers of the head and neck (HN) are heterogeneous tumors with incidence rates varying globally. In Northern Europe oral and oropharyngeal cancers are the most common individual types. Survival for HN varies by individual tumor type but for most of them survival trends are not well known over extended periods of time. METHODS: Data for a retrospective survival study were obtained for Danish, Finnish, Norwegian, and Swedish patients from the NORDCAN database from 1971 to 2020. Relative 1- and 5-year survival rates and 5/1-year conditional survival for years 2-5 were calculated. RESULTS: Both 1- and 5-year survival improved for all HN cancers but only marginally for laryngeal cancer. For the other cancers a 50-year increase in 5-year survival was about 30% units for nasopharyngeal and oropharyngeal cancers, 20% units for oral cancer and somewhat less for hypopharyngeal cancer. CONCLUSIONS: 5-year survival reached about 65% for all HN cancers, except for hypopharyngeal cancer (30%). Human papilloma virus infection is becoming a dominant risk factor for the rapidly increasing oropharyngeal cancer, the prevention of which needs to emphasize oral sex as a route of infection.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24020054
003      
CZ-PrNML
005      
20241024110910.0
007      
ta
008      
241015s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/cam4.6867 $2 doi
035    __
$a (PubMed)38164108
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Zitricky, Frantisek $u Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Pilsen, Czech Republic $1 https://orcid.org/0000000176007143
245    10
$a Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century / $c F. Zitricky, AI. Koskinen, O. Hemminki, A. Försti, A. Hemminki, K. Hemminki
520    9_
$a BACKGROUND: Cancers of the head and neck (HN) are heterogeneous tumors with incidence rates varying globally. In Northern Europe oral and oropharyngeal cancers are the most common individual types. Survival for HN varies by individual tumor type but for most of them survival trends are not well known over extended periods of time. METHODS: Data for a retrospective survival study were obtained for Danish, Finnish, Norwegian, and Swedish patients from the NORDCAN database from 1971 to 2020. Relative 1- and 5-year survival rates and 5/1-year conditional survival for years 2-5 were calculated. RESULTS: Both 1- and 5-year survival improved for all HN cancers but only marginally for laryngeal cancer. For the other cancers a 50-year increase in 5-year survival was about 30% units for nasopharyngeal and oropharyngeal cancers, 20% units for oral cancer and somewhat less for hypopharyngeal cancer. CONCLUSIONS: 5-year survival reached about 65% for all HN cancers, except for hypopharyngeal cancer (30%). Human papilloma virus infection is becoming a dominant risk factor for the rapidly increasing oropharyngeal cancer, the prevention of which needs to emphasize oral sex as a route of infection.
650    _2
$a lidé $7 D006801
650    12
$a nádory hrtanu $x mortalita $x epidemiologie $7 D007822
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a retrospektivní studie $7 D012189
650    12
$a nádory hltanu $x mortalita $x epidemiologie $7 D010610
650    _2
$a lidé středního věku $7 D008875
650    _2
$a míra přežití $7 D015996
650    _2
$a nádory úst $x mortalita $x epidemiologie $7 D009062
650    _2
$a senioři $7 D000368
650    _2
$a incidence $7 D015994
650    _2
$a rizikové faktory $7 D012307
651    _2
$a Skandinávie a severské státy $x epidemiologie $7 D012537
655    _2
$a časopisecké články $7 D016428
700    1_
$a Koskinen, Anni I $u Department of Otorhinolaryngology- Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
700    1_
$a Hemminki, Otto $u Department of Urology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland $u Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland
700    1_
$a Försti, Asta $u Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany $u Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany
700    1_
$a Hemminki, Akseli $u Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland $u Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland $1 https://orcid.org/0000000171038530
700    1_
$a Hemminki, Kari $u Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Pilsen, Czech Republic $u Division of Cancer Epidemiology, German Cancer Research Centre (DKFZ), Heidelberg, Germany $1 https://orcid.org/0000000227693316 $7 mzk20201092711
773    0_
$w MED00181704 $t Cancer medicine $x 2045-7634 $g Roč. 13, č. 1 (2024), s. e6867
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38164108 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024110904 $b ABA008
999    __
$a ok $b bmc $g 2202348 $s 1232027
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 13 $c 1 $d e6867 $e 20240102 $i 2045-7634 $m Cancer medicine $n Cancer Med $x MED00181704
GRA    __
$p European Union's Horizon 2020, grant no. 856620 (Chaperon)
LZP    __
$a Pubmed-20241015

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace